Search Results - "Kontoyianni, Maria"

Refine Results
  1. 1

    Docking and Virtual Screening in Drug Discovery by Kontoyianni, Maria

    “…Stages in a typical drug discovery organization include target selection, hit identification, lead optimization, preclinical and clinical studies. Hit…”
    Get more information
    Journal Article
  2. 2

    G Protein Coupled Receptors And Structure-Based Advances by Kontoyianni, Maria

    Published in Current topics in medicinal chemistry (01-05-2016)
    “…G protein coupled receptors (GPCRs) are membrane proteins coupled with G proteins through which they transmit signals to the cytoplasm. Approximately 30% of…”
    Get more information
    Journal Article
  3. 3

    Equilibrium landscape of ingress/egress channels and gating residues of the Cytochrome P450 3A4 by Ackad, Edward Michael, Biggers, Laurence, Meister, Mary, Kontoyianni, Maria

    Published in PloS one (18-03-2024)
    “…The Cytochrome P450 (CYP) enzymes metabolize a variety of drugs, which may potentially lead to toxicity or reduced efficacy when drugs are co-administered…”
    Get full text
    Journal Article
  4. 4

    Decoding Protein-protein Interactions: An Overview by Slater, Olivia, Miller, Bethany, Kontoyianni, Maria

    Published in Current topics in medicinal chemistry (01-01-2020)
    “…Drug discovery has focused on the paradigm "one drug, one target" for a long time. However, small molecules can act at multiple macromolecular targets, which…”
    Get more information
    Journal Article
  5. 5

    A computational study of somatostatin subtype-4 receptor agonist binding by Slater, Olivia, Kontoyianni, Maria

    Published in SN applied sciences (01-05-2022)
    “…The somatostatin subtype-4 receptor (sst 4 ) is highly expressed in neocortical and hippocampal areas, which are affected by amyloid beta accumulation. Sst 4…”
    Get full text
    Journal Article
  6. 6

    Evaluation of Docking Performance:  Comparative Data on Docking Algorithms by Kontoyianni, Maria, McClellan, Laura M, Sokol, Glenn S

    Published in Journal of medicinal chemistry (29-01-2004)
    “…Docking molecules into their respective 3D macromolecular targets is a widely used method for lead optimization. However, the best known docking algorithms…”
    Get full text
    Journal Article
  7. 7

    RSK1 vs. RSK2 Inhibitory Activity of the Marine β-Carboline Alkaloid Manzamine A: A Biochemical, Cervical Cancer Protein Expression, and Computational Study by Mayer, Alejandro M S, Hall, Mary L, Lach, Joseph, Clifford, Jonathan, Chandrasena, Kevin, Canton, Caitlin, Kontoyianni, Maria, Choo, Yeun-Mun, Karan, Dev, Hamann, Mark T

    Published in Marine drugs (07-09-2021)
    “…Manzamines are complex polycyclic marine-derived β-carboline alkaloids with reported anticancer, immunostimulatory, anti-inflammatory, antibacterial,…”
    Get full text
    Journal Article
  8. 8

    Theoretical and practical considerations in virtual screening: a beaten field? by Kontoyianni, Maria, Madhav, Prakash, Suchanek, Eric, Seibel, William

    Published in Current medicinal chemistry (2008)
    “…In this review, several aspects of virtual screening are presented. Although, docking and scoring have been the most widely employed techniques, ligand-based…”
    Get more information
    Journal Article
  9. 9
  10. 10

    The compromise of virtual screening and its impact on drug discovery by Slater, Olivia, Kontoyianni, Maria

    Published in Expert opinion on drug discovery (03-07-2019)
    “…: Docking and structure-based virtual screening (VS) have been standard approaches in structure-based design for over two decades. However, our understanding…”
    Get more information
    Journal Article
  11. 11

    Elucidating Substrate Promiscuity in the Human Cytochrome 3A4 by Hayes, Christina, Ansbro, Daniel, Kontoyianni, Maria

    “…The human cytochrome P450 enzymes (CYPs) are heme-protein monooxygenases, which catalyze oxidative reactions of a broad spectrum of substrates. Consequently,…”
    Get full text
    Journal Article
  12. 12

    Active Site of Bee Venom Phospholipase A2:  The Role of Histidine-34, Aspartate-64 and Tyrosine-87 by Annand, Robert R, Kontoyianni, Maria, Penzotti, Julie E, Dudler, Thomas, Lybrand, Terry P, Gelb, Michael H

    Published in Biochemistry (Easton) (09-04-1996)
    “…In bee venom phospholipase A2, histidine-34 probably functions as a Brønsted base to deprotonate the attacking water. Aspartate-64 and tyrosine-87 form a…”
    Get full text
    Journal Article
  13. 13

    Discovery of a 3,4,5-trisubstituted-1,2,4-triazole agonist with high affinity and selectivity at the somatostatin subtype-4 (sst 4 ) receptor by Daryaei, Iman, Sandoval, Karin, Witt, Ken, Kontoyianni, Maria, Michael Crider, A

    Published in MedChemComm (01-12-2018)
    “…A series of compounds containing a 1,2,4-triazole moiety were synthesized, targeting the somatostatin receptor subtype-4 (sst ). Compounds were developed in…”
    Get full text
    Journal Article
  14. 14

    Preferential Binding of the Marine β‐carboline Manzamine A to the NTDK Domain of RSK1 by Mayer, Alejandro, Hall, Mary, Lach, Joseph, Clifford, Jonathan, Chandrasena, Kevin, Canton, Caitlin, Kontoyianni, Maria

    Published in The FASEB journal (01-04-2015)
    “…Abstract only We reported that manzamine A (MZA) inhibited LPS‐treated rat microglia TXB 2 (IC 50 <0.016 µM) and O 2 ‐ (IC 50 =0.1 µM) generation (BMC…”
    Get full text
    Journal Article
  15. 15

    Discovery of a 3,4,5-trisubstituted-1,2,4-triazole agonist with high affinity and selectivity at the somatostatin subtype-4 (sst4) receptorElectronic supplementary information (ESI) available. See DOI: 10.1039/c8md00388b by Daryaei, Iman, Sandoval, Karin, Witt, Ken, Kontoyianni, Maria, Michael Crider, A

    Published 12-12-2018
    “…A series of compounds containing a 1,2,4-triazole moiety were synthesized, targeting the somatostatin receptor subtype-4 (sst 4 ). Compounds were developed in…”
    Get full text
    Journal Article
  16. 16

    Discovery of a 3,4,5-trisubstituted-1,2,4-triazole agonist with high affinity and selectivity at the somatostatin subtype-4 (sst4) receptor† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8md00388b by Daryaei, Iman, Sandoval, Karin, Witt, Ken, Kontoyianni, Maria, Michael Crider, A.

    Published in MedChemComm (07-11-2018)
    “…A 1,2,4-triazole has been discovered with high affinity and selectivity at the somatostatin sub-type 4 (sst 4 ) receptor. A series of compounds containing a…”
    Get full text
    Journal Article
  17. 17

    Development of a Simple and Effective Lipid‑A Antagonist Based on Computational Prediction by Slater, Olivia, Dhami, Kapur B., Shrestha, Ganesh, Kontoyianni, Maria, Nichols, Michael R., Demchenko, Alexei V.

    Published in ACS infectious diseases (10-06-2022)
    “…Sepsis is a serious medical condition characterized by bacterial infection and a subsequent massive systemic inflammatory response. In an effort to identify…”
    Get full text
    Journal Article
  18. 18

    Functional Prediction of Binding Pockets by Kontoyianni, Maria, Rosnick, Christopher B

    “…Putative function for targets with no known ligands has typically been determined from liganded homologous proteins using sequence and structure comparisons…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Identification of key residues involved in the activation and signaling properties of dopamine D3 receptor by Kota, Kokila, Kuzhikandathil, Eldo V., Afrasiabi, Milad, Lacy, Brett, Kontoyianni, Maria, Crider, A. Michael, Song, Daniel

    Published in Pharmacological research (01-09-2015)
    “…The dopamine D3 receptor exhibits agonist-dependent tolerance and slow response termination (SRT) signaling properties that distinguish it from the…”
    Get full text
    Journal Article